CompanyAKTSNasdaqBoston, MA

Aktis Oncology, Inc.

Clinical-stage oncology company developing targeted radiopharmaceuticals.

SEC EDGAR ClinicalTrials.gov aktisoncology.com

10-QAug 13Latest SEC filing, period to Jun 30

Aug 13Latest story

August 2026

Aktis Oncology reports Q2 2026 results, three Phase 1b trials now underway or cleared

Aug 13Quarterly updateAktis Oncology, Inc.